İkbal İNANLI, İbrahim EREN, Harun SÜSLÜ, Mustafa YILDIZ

Evaluaton of regional cerebral blood flow alterations by limbic activation in patients with schizophrenia

The aim of study is to evaluate the functions of limbic system in schizophrenia by performing procaine administration and using single photon emission computed tomography (SPECT). 22 patients and 19 controls were included in the study. Patients were evaluated with Positive and Negative Syndrome Scale (PANSS), Brief Psychiatric Rating Scale (BPRS), Hamilton Rating Scale for Depression (HAM-D) and Hamilton Rating Scale for Anxiety (HAM-A), Calgary Depression Rating Scale for Schizophrenia (CDSS) and the controls were evaluated with BPRS, HAM-D and HAM-A. The regional cerebral blood flow (rCBF) values were measured by SPECT. The rCBF following placebo and the alteration ratios of the rCBF following procaine of patients compared to controls. The rCBF following placebo in bilateral frontal, bilateral superior temporal, bilateral parahippocampus, thalamus, insula and alteration ratios of rCBF following procaine in bilateral anterior cingulate cortex (ACC) and left thalamus of patients were lower. Poor limbic activation to procaine was observed in the ACC and left thalamus of patients with schizophrenia. These findings support that the ACC and thalamus are crucial role in pathophysiology of schizophrenia.

PDF

___

H, Mokhber N, Azarpazhooh MR, Haghighi MB, Radmard M. A magnetic resonance Haghir imaging study of adhesio interthalamica in clinical subtypes of schizophrenia. Indian J Psychiatry. 2013;55:135-9.

Andreasen NC, O’Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL et al. Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 1997;349:1730-34.

Fujiwara H, Yassin W, Murai T. Neuroimaging studies of social cognition in schizophrenia. Psychiatry Clin Neurosci. 2015; 69:259-67.

Mesulam MM. Davranışsal ve kognitif nörolojinin ilkeleri (Çev Ed I. Hakan Gurvit), Yelkovan Yayincilik, Istanbul, 2004.

Lahti AC, Weiler M, Holcomb HH, et al. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology. 2006;31 221-30.

Belujon P, Patton MH, Grace A. Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia. Cereb Cortex. 2014;24:968-77.

Yamasue H, Iwanami A, Hirayasu Y, et al. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: An MRI parcellation study. Psychiatry Res - Neuroimaging. 2004;131:195-207.

Hazlett E, Buchsbaum MS, Kemether E, et al. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am J Psychiatry. 2004;161:305-14.

Whitford TJ, Lee SW, Oh JS, et al. Localized abnormalities in the cingulum bundle in patients with schizophrenia: A Diffusion Tensor tractography study. NeuroImage Clin. 2014;5:93-9.

Adinoff B, Devous MD, Best SE, et al. Dose-response measures of rCBF and subjective changes following procaine in healthy female volunteers. Psychiatry Res-Neuroimaging. 2002;114:123-35.

Benson BE, Carson RE, Kiesewetter DO, et al. A potential cholinergic mechanism of procaine’s limbic activation. Neuropsychopharmacology. 2004;29:1239-50.

Adinoff B, Devous MD, Best SE, et al. Gender differences in limbic responsiveness, by SPECT, following a pharmacologic challenge in healthy subjects Neuroimage. 2003a;18:697-706

Dieleman S & Röder, CH. Emotional memory modulation in schizophrenia: an overview. Acta Psychiatr Scand. 2013;127:183-94.

Adinoff, B, Devous, MD, Best, et al. Limbic responsiveness to procaine in cocaine-addicted subjects. Am J Psychiatry 2001;158:390-8.

Adinoff B, Devous MD, Best SE, et al. Regional cerebral blood flow in female cocaine-addicted subjects following limbic activation. Drug Alcohol Depend. 2003b;71:255-68.

Adinoff B, Devous MD Sr, Cooper DC, et al. Neural response to lidocaine in healthy subjects. Psychiatry Res. 2009;27:417-28

Yürekli Y, Bodur Z, Gülseren L, et al. Comparison of regional cerebral blood flow in deficit and nondeficit schizophrenic patients. Turk Psikiyatri Derg. 2003;14:255-62.

Hu M, Li J, Eyler L, et al. Decreased left middle temporal gyrus volume in antipsychotic drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings. Schizophr Res. 2013;144:37-42.

Yamada M, Hirao K, Namiki C, et al. Social cognition and frontal lobe pathology in schizophrenia: A voxel-based morphometric study. Neuroimage. 2007;35:292-8.

Chen J, Wei D, Yang L, et al. Neurocognitive impairment on motor imagery associated with positive symptoms in patients with fi rst-episode schizophrenia : Evidence from event-related brain potentials. Psychiatry Res Neuroimaging. 2015;231:236-43.

Malaspina D, Harkavy-Friedman J, Corcoran C, et al. Resting neural activity distinguishes subgroups of schizophrenia patients. Biol Psychiatry. 2004;56:931-7.

Lahti AC, Weiler M, Holcomb HH, et al. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology. 2006;31:221-30.

Nelson BD, Bjorkquist OA, Olsen EK, et al. Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation. Psychiatry Res. 2015;30;234:285-91.

Pergola G, Selvaggi P, Trizio S, et al. The role of the thalamus in schizophrenia from a neuroimaging perspective. Neurosci Biobehav Rev. 2015;54:57-75.

Wang H-LS, Ra C-L, Li Y-M, et al. Disrupted thalamic resting-state functional networks in schizophrenia. Front Behav Neurosci. 2015;9:1-9.

Friedman JI. Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology. 2004;174:45-53.

Raedler TJ, Knable MB, Jones DW, et al. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am J Psychiatry. 2003;160:118-27.

Carruthers SP, Gurvich CT, Rossell SL. The muscarinic system, cognition and schizophrenia. Neurosc. Biobehav. Rev. 2015;55:393-402.

Zavitsanou K, Katsifis A, Mattner F, et al. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:355-60.

Sperling W, Müller H. Nucleus lentiformis - A new model for psychiatry? Med Hypotheses. 2011;76:720-2.